Shenzhen New Industries Biomedical (300832) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.069x

Based on the latest financial reports, Shenzhen New Industries Biomedical (300832) has a cash flow conversion efficiency ratio of 0.069x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥606.21 Million ≈ $88.71 Million USD) by net assets (CN¥8.74 Billion ≈ $1.28 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Shenzhen New Industries Biomedical's balance sheet to measure how much of total assets are equity-financed.

Shenzhen New Industries Biomedical - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Shenzhen New Industries Biomedical's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Shenzhen New Industries Biomedical (300832) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Shenzhen New Industries Biomedical Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shenzhen New Industries Biomedical ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
UPL Limited NSE:UPL	-0.128x
MGIC Investment Corp NYSE:MTG	0.015x
Mercury General Corporation NYSE:MCY	0.126x
Hankook Tire Co. KO:161390	0.027x
Shenzhen Everwin Precision Tech SHE:300115	-0.016x
Valmet Oyj HE:VALMT	0.038x
Neway Valve suzhou Co Ltd SHG:603699	0.151x
GUANGDONG INV.UNSP.ADR/50 F:GUG0	N/A

Annual Cash Flow Conversion Efficiency for Shenzhen New Industries Biomedical (2012–2024)

The table below shows the annual cash flow conversion efficiency of Shenzhen New Industries Biomedical from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see 300832 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥8.58 Billion ≈ $1.26 Billion	CN¥1.36 Billion ≈ $198.49 Million	0.158x	-15.87%
2023-12-31	CN¥7.54 Billion ≈ $1.10 Billion	CN¥1.42 Billion ≈ $207.54 Million	0.188x	+25.01%
2022-12-31	CN¥6.40 Billion ≈ $936.45 Million	CN¥962.39 Million ≈ $140.83 Million	0.150x	+9.15%
2021-12-31	CN¥5.61 Billion ≈ $821.21 Million	CN¥773.22 Million ≈ $113.15 Million	0.138x	-32.23%
2020-12-31	CN¥4.80 Billion ≈ $703.01 Million	CN¥976.65 Million ≈ $142.92 Million	0.203x	-23.28%
2019-12-31	CN¥3.14 Billion ≈ $459.30 Million	CN¥831.73 Million ≈ $121.71 Million	0.265x	-10.68%
2018-12-31	CN¥2.37 Billion ≈ $346.26 Million	CN¥701.97 Million ≈ $102.72 Million	0.297x	+0.19%
2017-12-31	CN¥1.77 Billion ≈ $259.33 Million	CN¥524.73 Million ≈ $76.78 Million	0.296x	-13.68%
2016-12-31	CN¥1.42 Billion ≈ $207.68 Million	CN¥486.81 Million ≈ $71.24 Million	0.343x	+14.71%
2015-12-31	CN¥1.02 Billion ≈ $149.72 Million	CN¥305.93 Million ≈ $44.77 Million	0.299x	-27.98%
2014-12-31	CN¥610.52 Million ≈ $89.34 Million	CN¥253.47 Million ≈ $37.09 Million	0.415x	+13.70%
2013-12-31	CN¥378.84 Million ≈ $55.44 Million	CN¥138.33 Million ≈ $20.24 Million	0.365x	+62.39%
2012-12-31	CN¥248.18 Million ≈ $36.32 Million	CN¥55.80 Million ≈ $8.17 Million	0.225x	--

About Shenzhen New Industries Biomedical

SHE:300832 China Medical Devices

Market Cap

$5.51 Billion

CN¥37.68 Billion CNY

Market Cap Rank

#3327 Global

#433 in China

Share Price

CN¥47.95

Change (1 day)

+0.17%

52-Week Range

CN¥39.45 - CN¥70.18

All Time High

CN¥98.01